Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > PROXY

<< Previous

Bullboard Posts

Next >>

Comment by waynedon Jun 14, 2013 6:27pm

299 Views

Post# 21527125

RE: RE: PROXY

I don`t understand why any one would be buying shares now . Do they not understand in two weeks they will receive only ( 2/3 ) two thirds of a share for every share they hold now ? Possibly even less . There is a 40 cent warrant for one year but insiders get their warrants at 20 cents and they are good for five years . What are the chances of your approx. 2 cent Halo shares going to a break even 40 cent warrant in a year ? Nil I would say . But insiders can wait five years and half the price . As usual the little guy gets shafted so once again ., why would anybody with half a clue be buying now ? Oh , 2 cents is the value of your Halo shares after the merger.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages